Medical Educational Resource
Respiratory Manifestations in Neuromuscular Disorders
This program is supported in part by Hillrom.
An overview of best practices to manage respiratory manifestations in patients living with neuromuscular disease (NMD). This webinar provides education for healthcare providers on the benefits of implementing early and ongoing pulmonary function assessments in the course of NMD management, use of non-invasive ventilators and airway clearance devices, considerations for instructing patients on at-home management of respiratory infections, and rehabilitation approaches to improve respiratory function.
- Recognize the benefits of implementing early and ongoing pulmonary function assessments and interventions in the course of Neuromuscular Disease (NMD) management
- Recognize the features of and indications for non-invasive ventilators and understand the use of airway clearance devices in the management of NMD
- Instruct patients and caregivers on how to prevent and treat early stages of respiratory infections at home
- Utilize rehabilitation approaches to preserve or improve respiratory function in NMD
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Muscular Dystrophy Association. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.
The PeerPoint Medical Education Institute, LLC designates this live Internet activity for a maximum of 1.75 AMA PRA Category 2 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dates: March 15, 2021 – March 15, 2022
Once you have viewed the program, MDA will share back with you instructions for how to obtain your CME credits. If you have questions on this process, please reach out to email@example.com.
The following presenters, planners, editors, or staff have relevant financial relationships to disclose:
“I, or an immediate family member, have at present or have had within the last 12 months, the following affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities.”
Dr. Rabia Malik
Ra Pharma: Site Principal Investigator (PI); Research Funding
PCORI: Site PI; Research Funding
MDA: Travel and Speaking; Honorarium
Dr. Jason Thomas Ackrivo
Hillrom: Advisory Committee; Consulting Fees
All other presenters, planners, editors, or staff reported no relevant relationships with the following statement:
“I, or an immediate family member, do not have at present, or within the last 12 months, nor anticipate having financial interest, arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities.”
Copyright 2021 Muscular Dystrophy Association. All rights reserved. The Medical Education Program(s) in their entirety (including, but not limited to: webinar(s), speaker deck presentation(s), MDA Monthly Report content and case studies) are owned by Muscular Dystrophy Association and the associated partner(s) and may not be copied, reproduced, or altered in any manner without MDA’s prior written consent except that the User(s) may download, view, or use these program(s) for educational purposes only.
If you wish to alter any of the Medical Education Program(s) presented by the MDA in a form other than what is set out on mda.org, please consult firstname.lastname@example.org.